Zapata Quantum Financials
This page shows Zapata Quantum (ZPTA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Zapata Quantum has an operating margin of -88.4%, meaning the company retains $-88 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -594.6% the prior year.
Zapata Quantum's revenue grew a modest 0.0% year-over-year to $3.9M. This slow but positive growth earns a score of 33/100.
Zapata Quantum's current ratio of 0.17 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 0/100, which could limit financial flexibility.
While Zapata Quantum generated -$1.7M in operating cash flow, capex of $34K consumed most of it, leaving -$1.7M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Zapata Quantum passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Zapata Quantum generates $-0.18 in operating cash flow (-$1.7M OCF vs $9.3M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Zapata Quantum earns $-6.7 in operating income for every $1 of interest expense (-$3.4M vs $513K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Zapata Quantum generated $3.9M in revenue in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Zapata Quantum's EBITDA was -$3.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 85.6% from the prior year.
Zapata Quantum reported $9.3M in net income in fiscal year 2025. This represents an increase of 124.5% from the prior year.
Zapata Quantum earned $0.04 per diluted share (EPS) in fiscal year 2025. This represents an increase of 103.1% from the prior year.
Cash & Balance Sheet
Zapata Quantum generated -$1.7M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 90.6% from the prior year.
Zapata Quantum held $0 in cash against $2.5M in long-term debt as of fiscal year 2025.
Zapata Quantum had 172M shares outstanding in fiscal year 2025. This represents an increase of 295.3% from the prior year.
Margins & Returns
Zapata Quantum's gross margin was 16.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.0 percentage points from the prior year.
Zapata Quantum's operating margin was -88.4% in fiscal year 2025, reflecting core business profitability. This is up 506.2 percentage points from the prior year.
Zapata Quantum's net profit margin was 240.9% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1225.0 percentage points from the prior year.
Capital Allocation
Zapata Quantum invested $252K in research and development in fiscal year 2025. This represents a decrease of 94.3% from the prior year.
Zapata Quantum invested $34K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 0.0% from the prior year.
ZPTA Income Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | $0-100.0% | $657K-67.2% | $2.0M+64.3% | $1.2M-8.4% | $1.3M |
| Cost of Revenue | N/A | N/A | N/A | -$4K-100.4% | $913K-28.7% | $1.3M+21.7% | $1.1M+16.4% | $904K |
| Gross Profit | N/A | N/A | N/A | $4K+101.6% | -$256K-135.5% | $721K+334.3% | $166K-60.9% | $425K |
| R&D Expenses | N/A | N/A | N/A | $49K-96.4% | $1.4M-13.9% | $1.6M+13.2% | $1.4M+71.4% | $821K |
| SG&A Expenses | $1.0M+75.2% | $584K-14.1% | $680K-60.0% | $1.7M-56.6% | $3.9M-8.8% | $4.3M+95.2% | $2.2M-8.5% | $2.4M |
| Operating Income | -$1.0M-76.2% | -$584K+14.1% | -$680K+77.2% | -$3.0M+61.0% | -$7.6M-3.4% | -$7.4M-45.2% | -$5.1M-26.0% | -$4.0M |
| Interest Expense | $136K-3.5% | $141K+38.2% | $102K+121.7% | $46K-16.4% | $55K-28.6% | $77K-90.2% | $784K+1593.9% | $46K |
| Income Tax | N/A | N/A | N/A | $0-100.0% | $7K0.0% | $7K+16.7% | $6K+166.7% | -$9K |
| Net Income | $3.3M+20.9% | $2.7M+450.6% | -$770K+79.4% | -$3.7M-207.1% | $3.5M+122.4% | -$15.6M+30.2% | -$22.3M-52.9% | -$14.6M |
| EPS (Diluted) | $0.02-50.0% | $0.04+300.0% | $-0.02 | N/A | $0.09+118.8% | $-0.48+88.3% | $-4.09 | N/A |
ZPTA Balance Sheet
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.3M-12.4% | $3.8M+46.7% | $2.6M-6.0% | $2.7M-58.2% | $6.5M-41.5% | $11.2M+13.5% | $9.9M+22.2% | $8.1M |
| Current Assets | $2.8M-13.4% | $3.3M+60.0% | $2.0M-6.2% | $2.2M-66.2% | $6.5M-41.3% | $11.0M+15.0% | $9.6M+71.2% | $5.6M |
| Cash & Equivalents | $919K-32.2% | $1.4M+370.8% | $288K+657.9% | $38K-98.5% | $2.5M-62.6% | $6.7M+10.2% | $6.0M+124.2% | $2.7M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | $1.6M | N/A | N/A | N/A | $829K |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $19.4M-16.3% | $23.1M-13.6% | $26.8M+2.2% | $26.2M-0.6% | $26.4M-30.9% | $38.1M+23.3% | $30.9M-62.7% | $83.0M |
| Current Liabilities | $18.1M-17.4% | $21.9M-10.3% | $24.5M+3.4% | $23.7M+8.5% | $21.8M-4.8% | $22.9M-1.0% | $23.1M+146.4% | $9.4M |
| Long-Term Debt | $1.2M+3.3% | $1.2M-48.3% | $2.3M-9.3% | $2.5M-8.3% | $2.8M+33.5% | $2.1M-5.0% | $2.2M-75.4% | $8.9M |
| Total Equity | -$16.1M+17.1% | -$19.4M+20.0% | -$24.2M-3.2% | -$23.5M-18.4% | -$19.8M+26.5% | -$27.0M-27.9% | -$21.1M+71.9% | -$74.9M |
| Retained Earnings | -$122.5M+2.6% | -$125.7M+2.1% | -$128.4M-0.6% | -$127.7M-3.0% | -$123.9M+2.7% | -$127.4M-13.9% | -$111.8M-24.9% | -$89.5M |
ZPTA Cash Flow Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$521K-28.6% | -$405K-586.4% | -$59K+98.0% | -$3.0M+56.0% | -$6.8M-12.1% | -$6.1M-184.4% | -$2.1M+9.7% | -$2.4M |
| Capital Expenditures | N/A | N/A | N/A | $0-100.0% | $8K-46.7% | $15K+36.4% | $11K | N/A |
| Free Cash Flow | N/A | N/A | N/A | -$3.0M+56.1% | -$6.9M-11.9% | -$6.1M-183.7% | -$2.2M | N/A |
| Investing Cash Flow | N/A | N/A | N/A | $0+100.0% | -$8K+46.7% | -$15K-36.4% | -$11K | $0 |
| Financing Cash Flow | $100K | N/A | N/A | $149K-94.7% | $2.8M-53.9% | $6.1M-0.7% | $6.1M+155.2% | $2.4M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $0 |
ZPTA Financial Ratios
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | -39.0%-75.0pp | 36.0%+22.4pp | 13.6%-18.3pp | 32.0% |
| Operating Margin | N/A | N/A | N/A | N/A | -1160.1%-791.7pp | -368.4%+48.3pp | -416.8%-113.6pp | -303.2% |
| Net Margin | N/A | N/A | N/A | N/A | 530.0%+1308.4pp | -778.4%+1054.1pp | -1832.5%-734.3pp | -1098.2% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | 98.9%+27.2pp | 71.7%+101.6pp | -30.0%+106.5pp | -136.4%-189.6pp | 53.2%+192.4pp | -139.2%+87.3pp | -226.5%-45.6pp | -180.9% |
| Current Ratio | 0.160.0 | 0.15+0.1 | 0.080.0 | 0.09-0.2 | 0.30-0.2 | 0.48+0.1 | 0.41-0.2 | 0.60 |
| Debt-to-Equity | -0.08-0.0 | -0.06+0.0 | -0.10+0.0 | -0.11+0.0 | -0.14-0.1 | -0.08+0.0 | -0.10+0.0 | -0.12 |
| FCF Margin | N/A | N/A | N/A | N/A | -1043.1%-737.1pp | -305.9%-128.8pp | -177.2% | N/A |
Note: Shareholder equity is negative (-$8.3M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.17), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Zapata Quantum's annual revenue?
Zapata Quantum (ZPTA) reported $3.9M in total revenue for fiscal year 2025. This represents a 0.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Zapata Quantum's revenue growing?
Zapata Quantum (ZPTA) revenue grew by 0% year-over-year, from $3.9M to $3.9M in fiscal year 2025.
Is Zapata Quantum profitable?
Yes, Zapata Quantum (ZPTA) reported a net income of $9.3M in fiscal year 2025, with a net profit margin of 240.9%.
What is Zapata Quantum's EBITDA?
Zapata Quantum (ZPTA) had EBITDA of -$3.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Zapata Quantum have?
As of fiscal year 2025, Zapata Quantum (ZPTA) had $0 in cash and equivalents against $2.5M in long-term debt.
What is Zapata Quantum's gross margin?
Zapata Quantum (ZPTA) had a gross margin of 16.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Zapata Quantum's operating margin?
Zapata Quantum (ZPTA) had an operating margin of -88.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Zapata Quantum's net profit margin?
Zapata Quantum (ZPTA) had a net profit margin of 240.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Zapata Quantum's free cash flow?
Zapata Quantum (ZPTA) generated -$1.7M in free cash flow during fiscal year 2025. This represents a 90.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Zapata Quantum's operating cash flow?
Zapata Quantum (ZPTA) generated -$1.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Zapata Quantum's total assets?
Zapata Quantum (ZPTA) had $2.3M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Zapata Quantum's capital expenditures?
Zapata Quantum (ZPTA) invested $34K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Zapata Quantum spend on research and development?
Zapata Quantum (ZPTA) invested $252K in research and development during fiscal year 2025.
What is Zapata Quantum's current ratio?
Zapata Quantum (ZPTA) had a current ratio of 0.17 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Zapata Quantum's debt-to-equity ratio?
Zapata Quantum (ZPTA) had a debt-to-equity ratio of -0.31 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Zapata Quantum's return on assets (ROA)?
Zapata Quantum (ZPTA) had a return on assets of 410.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Zapata Quantum's cash runway?
Based on fiscal year 2025 data, Zapata Quantum (ZPTA) had $0 in cash against an annual operating cash burn of $1.7M. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Zapata Quantum's debt-to-equity ratio negative or unusual?
Zapata Quantum (ZPTA) has negative shareholder equity of -$8.3M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Zapata Quantum's Piotroski F-Score?
Zapata Quantum (ZPTA) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Zapata Quantum's earnings high quality?
Zapata Quantum (ZPTA) has an earnings quality ratio of -0.18x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Zapata Quantum cover its interest payments?
Zapata Quantum (ZPTA) has an interest coverage ratio of -6.7x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Zapata Quantum?
Zapata Quantum (ZPTA) scores 8 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.